CD8+ T cells were engineered to overexpress Tcf-1 and the 19,305-TCR and afterward implemented in co-cultures with SK-MEL-37 melanoma cells (SK37), a cell line that expresses NY-ESO-1 and HLA-A*02:01. The gene discussed is CD8A; the disease is melanoma.